Document Detail


A comparison of the effects of dopexamine and prostacyclin in systemic inflammatory response syndrome.
MedLine Citation:
PMID:  10455827     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty critically ill patients fulfilling the definitions of systemic inflammatory response syndrome were enrolled in a double-blind cross-over interventional study assessing the effects of dopexamine and prostacyclin on splanchnic perfusion, cardiovascular function and oxygen flux. The cross-over design involved either dopexamine (1.25 micrograms.kg-1.min-1) or prostacyclin (0.5 ng.kg-1.min-1) being infused for 6 h followed by a 12-h washout period prior to an identical infusion sequence using the other agent. Preliminary analysis revealed a significant period effect, so data from the second infusion period were excluded from further analysis. Dopexamine caused a significant increase in heart rate (116 vs. 106 beat.min-1), and urine output (103 vs. 69 ml.h-1). Dopexamine produced a significant increase in oxygen delivery (infusion 548 ml O2.min-1.m-2; no infusion 492 ml O2.min-1.m-2) while prostacyclin caused a decrease (infusion 460 ml O2.min-1.m-2; no infusion 547 ml O2.min-1.m-2). The results indicate that dopexamine improves oxygen delivery and urine output more effectively than prostacyclin.
Authors:
M Blunt; P Young; S Ridley
Related Documents :
11837787 - Induced hypothermia after high-energy soft-tissue injury and subsequent hemorrhagic shock.
6113627 - Twenty-five years of treatment of circulatory failure.
1155327 - Effects of tachycardia on the adequacy of subendocardial oxygen delivery in experimenta...
22849707 - Neuro-ventilatory efficiency and extubation readiness in critically ill patients.
1393807 - Effect of combined peribulbar and retrobulbar injection of large volumes of anesthetic ...
602697 - The influence of pressure upon the fetal head during labour.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anaesthesia     Volume:  54     ISSN:  0003-2409     ISO Abbreviation:  Anaesthesia     Publication Date:  1999 Apr 
Date Detail:
Created Date:  1999-08-30     Completed Date:  1999-08-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370524     Medline TA:  Anaesthesia     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  313-9     Citation Subset:  AIM; IM    
Affiliation:
Norfolk & Nonvich Hospital, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / therapeutic use
Aged
Aged, 80 and over
Algorithms
Cross-Over Studies
Dopamine / analogs & derivatives*,  therapeutic use
Double-Blind Method
Epoprostenol / therapeutic use*
Hemodynamics / drug effects
Humans
Middle Aged
Platelet Aggregation Inhibitors / therapeutic use*
Splanchnic Circulation / drug effects
Systemic Inflammatory Response Syndrome / drug therapy*,  physiopathology
Vasodilator Agents / therapeutic use*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Platelet Aggregation Inhibitors; 0/Vasodilator Agents; 35121-78-9/Epoprostenol; 86197-47-9/dopexamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Overcome terminal seriousness: let go, laugh, and lighten up!
Next Document:  The effect of oxygen on propofol-induced inhibition of microsomal cytochrome P450 3A4.